A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg
Mario Festin(Khon Kaen University), Nathalie Kapp(International Planned Parenthood Federation), Thi My Huong Nguyen(World Health Organization), Manopchai Thamkhantho(Siriraj Hospital), Ndema Habib(World Health Organization), Arundhati Gosavi(National University of Singapore), Luís Bahamondes(Universidade Estadual de Campinas (UNICAMP)), Tamás Bitó(University of Szeged), M. Valeria Bahamondes(Universidade Estadual de Campinas (UNICAMP)), György Bártfai(University of Szeged), Kuldip Singh(University of Leicester)
Cited by 28
Related Papers
Medical methods for first trimester abortion
|Cochrane Database of Systematic Reviews|2011|288
Method of Delivery and Pregnancy Outcomes in Asia
|Obstetric Anesthesia Digest|2011|285
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|195
Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial
|Reproductive Health|2013|161
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men
|The Journal of Clinical Endocrinology & Metabolism|2016|139